# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-09T17:09:25.619678
**Route:** OpenRouter + LaTeX
**Paper Hash:** 9cce6aed48f35a7e
**Tokens:** 22034 in / 1806 out
**Response SHA256:** dea0a511497a4bc6

---

I checked the draft only for fatal errors in data-design alignment, regression sanity, completeness, and internal consistency.

I do **not** find any fatal errors.

Key checks completed:
- **Treatment timing vs. data coverage:** Main Kenya panel runs **2010–2023**, while treatment begins in **2016** and repeal in **2019**. Post-treatment periods are observed through **2023**, so timing is feasible.
- **Post-treatment observations:** The DiD has post-cap years **2017–2019** and post-repeal years **2020–2023**. Cross-country panel also covers post periods.
- **Treatment definition consistency:** The coding is consistent across text, equations, tables, and appendix: main DiD uses **2017–2019** as full cap years and **2020–2023** as post-repeal, while the event study separately treats **2016** as the transition year.
- **Regression sanity:** No impossible values, no negative SEs, no NA/NaN/Inf in tables, no R² outside [0,1], and no coefficients/SEs that are obviously broken by the thresholds you specified.
- **Completeness:** Regression tables report **sample sizes (N / Num. Obs.)** and **standard errors**. I do not see placeholder entries like TBD/TODO/XXX/NA in reported results tables. All referenced tables/figures/sections cited in the manuscript appear to exist in the source.
- **Internal consistency:** The summary statistics line up with the DiD magnitudes; the treatment chronology is consistent across sections; cross-country significance stars are consistent with very small-cluster inference.

ADVISOR VERDICT: PASS